Viewing nowCombinationClozartan Tablet 50/12.5 mg (Losartan, Chlorthalidone)
Chlorthalidone 12.5mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 202202297 · Approved 2022.05.31 · Insurance code 643508520
Treatment of hypertension not adequately controlled with losartan alone
In hypertensive patients for whom blood pressure is not adequately controlled by monotherapy with losartan, additional treatment may be necessary. It is recommended to consider combination therapy or the addition of other medications to enhance blood pressure control. These approaches help effectively lower blood pressure and reduce the risk of cardiovascular complications. Managing blood pressure is crucial for improving overall health and protecting the heart and blood vessels. Therefore, it is necessary to take appropriate measures to manage blood pressure stably.
○ Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using losartan potassium before administering this medicine. However, a direct switch to this medicine may be considered when blood pressure is not controlled with monotherapy using the individual components, as follows: - 50/6.25 milligrams, 50/12.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with losartan potassium 50 milligrams as monotherapy. - 100/12.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with losartan potassium 100 milligrams as monotherapy. ○ Elderly patients For elderly patients aged 75 years or older, the recommended initial dose of losartan potassium is 25 milligrams once daily. Since the initial dose of losartan potassium, 25mg, cannot be administered with this medicine, use for initial treatment in these patients is not recommended. ○ Patients with renal impairment No adjustment of the initial dose of losartan potassium is necessary in patients with creatinine clearance of 30~50mL/min. ○ Patients with hepatic impairment Since the initial dose of losartan potassium, 25 mg, for patients with a history of hepatic impairment requiring dose adjustment and for patients with hepatic impairment cannot be administered with this medicine, use for initial treatment in these patients is not recommended. ○ Patients with decreased effective intravascular volume Since the initial dose of losartan potassium, 25 mg, for patients who may have intravascular volume depletion cannot be administered with this medicine, use for initial treatment in these patients is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with impaired liver function or cirrhosis are at risk of hepatic encephalopathy when taking this medication, so caution is advised. This medication should not be used in patients with severe kidney disease, as some components may accumulate in the body and cause problems. It should be avoided by those with hypersensitivity to this medication or its components and certain liver or kidney diseases. Elderly patients, those with electrolyte imbalances, and patients with heart or vascular diseases should use this medication cautiously, and periodic blood pressure and blood tests are required during treatment. This medication may cause side effects such as dizziness, headache, dyspepsia, skin rash, and other abnormalities; if unusual symptoms occur, it is important to consult a healthcare professional. Serum potassium levels may increase, so co-administration with potassium supplements or potassium-sparing diuretics is not recommended. Care should be taken when combining this medication with other antihypertensives, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), etc., as interactions may result in side effects. Pregnant and nursing women should not take this medication; if necessary, breastfeeding should be discontinued. Safety in children has not been established, so it is not recommended. Overdosage may result in hypotension, tachycardia, electrolyte imbalances, etc., and immediate medical treatment is required. Keep this medication out of the reach of children and do not transfer it to another container.
COVID-19, dizziness, headache, abdominal distension, chronic gastritis, dyspepsia, gastroesophageal reflux disease, asthenia, gastroenteritis, herpes zoster, rhinitis, sinusitis, upper respiratory infection, femoral neck fracture, fracture, sprain, arthralgia, nasal congestion, productive cough, urticaria, diarrhea, nausea, contusion, limb injury, increased C-reactive protein, increased creatine phosphokinase in blood, increased liver enzymes, increased triglycerides in blood, orthostatic dizziness, nocturia, chest discomfort, influenza-like illness, pain, fever, tenderness, muscle strain, skin abrasion, hypokalemia, musculoskeletal pain, drowsiness, orthostatic hypotension, phlebitis, ventricular extrasystole, tinnitus, upper abdominal pain, enteritis, colon polyp, taste disturbance, dry cough, erythema multiforme, aplastic anemia, necrotizing vasculitis, pulmonary edema, pancreatitis, agranulocytosis, acute renal failure, toxic epidermal necrolysis, hyperkalemia, hyperuricemia, increased lipids in blood, hyponatremia, hypomagnesemia, hyperglycemia, gout, hypochloremic metabolic alkalosis, photosensitivity reactions, intrahepatic cholestasis, jaundice, orthostatic hypotension, deep vein thrombosis, palpitations, sensory disturbance, depression, heaviness, decreased appetite, mild gastrointestinal distress, nausea, vomiting, stomach pain, constipation, diarrhea, thrombocytopenia, leukopenia, agranulocytosis, eosinophilia, purpura, visual disturbances, jaundice, erectile dysfunction, nocturnal enuresis, frequent urination, urinary tract infection, facial swelling, fever, orthostatic effects, syncope, angina, second-degree atrioventricular block, cerebrovascular accident, hypotension, myocardial infarction, atrial fibrillation, palpitations, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, nausea, diarrhea, dyspepsia, cough, sinus disorders, pharyngitis, myalgia, insomnia, headache, weakness, fatigue, abdominal pain, chest pain, lip swelling, eyelid swelling, facial rash, palm desquamation, hemolysis, facial/lip/pharyngeal/tongue swelling, vasculitis, anaphylaxis-like syndrome, abnormal liver function, hepatitis, intestinal vascular edema, malaise, anemia, thrombocytopenia, rhabdomyolysis, acute renal failure, taste disturbance, dry cough, erythema multiforme, elevated ALT, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, renal failure, arrhythmia, hypoglycemia, muscle elasticity, muscle cramp, sensory disturbance, fatigue, somnolence, confusion, thirst, nausea, vomiting, polyuria, blood concentration, oliguria, anuria, venous thrombosis, drowsiness, hypovolemia, arrhythmia
Not everyone experiences these, and they can vary from person to person.
Store this medication in a sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationChlorthalidone 12.5mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationChlorthalidone 12.5mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationChlorthalidone 6.25mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.